Figure 3.
Structural correlation between the most active compound (15l) and CDK-1/cyclin B inhibitors (2, roscovitine and 3, NU-6102) and HER-2 inhibitor (7, gefitinib).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.